Apricus Biosciences, Inc.

DGAP-News: Apricus Biosciences vor Ubernahme des umsatzstarksten Vertriebs- und Marketingunternehmens fur Medikamente in Frankreich

Apricus Biosciences, Inc. 21.06.2012 22:44 --------------------------------------------------------------------------- Ubernahme von Finesco-Scomedica ermoglicht Apricus Bio die direkte Einfuhrung von Vitaros(R) und anderen Produkten in Frankreich, dem zweitgrossten Markt fur ...

21.06.2012 | Wirtschaft (allg.)

DGAP-News: Apricus Biosciences Announces Appointment of Paul V. Maier to Its Board of Directors

Apricus Biosciences, Inc. 04.06.2012 15:39 --------------------------------------------------------------------------- SAN DIEGO, 2012-06-04 15:39 CEST (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ('Apricus Bio') (Nasdaq:APRI) (www.apricusbio.com) today announced that Paul V. Maier, Ch ...

04.06.2012 | Wirtschaft (allg.)

DGAP-News: Apricus Biosciences Strengthens Vitaros(R) and Nexact(R) Patent Estate With Two New Patent Allowances

Apricus Biosciences, Inc. 25.05.2012 19:20 --------------------------------------------------------------------------- SAN DIEGO, 2012-05-25 19:20 CEST (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ('Apricus Bio' or the 'Company') (Nasdaq:APRI) (http://www.apricusbio.com), ann ...

25.05.2012 | Wirtschaft (allg.)

DGAP-News: Apricus Biosciences Granted Regulatory Guidance With FDA for MycoVa(TM) for the Treatment of Onychomycosis

Apricus Biosciences, Inc. 22.05.2012 16:13 --------------------------------------------------------------------------- SAN DIEGO, 2012-05-22 16:13 CEST (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ('Apricus Bio' or the 'Company') (Nasdaq:APRI) (http://www.apricusbi ...

22.05.2012 | Wirtschaft (allg.)

DGAP-News: Apricus Biosciences Granted Regulatory Meeting With FDA for Femprox(R) for the Treatment of Female Sexual Arousal Disorder

Apricus Biosciences, Inc. 21.05.2012 15:35 --------------------------------------------------------------------------- SAN DIEGO, 2012-05-21 15:35 CEST (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ('Apricus Bio' or the 'Company') (Nasdaq:APRI) (http://www.apricusbio.com) anno ...

21.05.2012 | Wirtschaft (allg.)

DGAP-News: Apricus Biosciences to Present at the 11th Annual JMP Securities Research Conference

Apricus Biosciences, Inc. 14.05.2012 15:42 --------------------------------------------------------------------------- SAN DIEGO, 2012-05-14 15:42 CEST (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ('Apricus Bio') (Nasdaq:APRI) announced today that Edward Cox, Vice President Corporate D ...

14.05.2012 | Wirtschaft (allg.)

DGAP-News: Health Canada Grants Apricus Biosciences Pre-NDS Meeting for MycoVa(TM) for the Treatment of Onychomycosis

Apricus Biosciences, Inc. 11.05.2012 15:55 --------------------------------------------------------------------------- SAN DIEGO, 2012-05-11 15:55 CEST (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ('Apricus Bio' or the 'Company') (Nasdaq:APRI) (http://www.apricusbio.com) anno ...

11.05.2012 | Wirtschaft (allg.)

DGAP-News: Apricus Biosciences Announces First Quarter 2012 Financial Results Conference Call and Provides Corporate Update

Apricus Biosciences, Inc. 08.05.2012 15:49 --------------------------------------------------------------------------- Conference Call/Webcast to be Held Thursday, May 10, 2012 at 4:30 p.m. ET SAN DIEGO, 2012-05-08 15:49 CEST (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ('Apricus Bio' ...

08.05.2012 | Wirtschaft (allg.)

DGAP-News: Health Canada Grants Apricus Biosciences Pre-NDS Meeting for Femprox for Female Sexual Arousal Disorder

Apricus Biosciences, Inc. 07.05.2012 16:10 --------------------------------------------------------------------------- SAN DIEGO, 2012-05-07 16:10 CEST (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ('Apricus Bio' or the 'Company') (Nasdaq:APRI) (http://www.apricusbio.com) anno ...

07.05.2012 | Wirtschaft (allg.)

DGAP-News: Apricus Biosciences Announces Poster Presentation of Femprox(R) Phase III Clinical Data at American Urological Association Annual Meeting

Apricus Biosciences, Inc. 04.05.2012 16:05 --------------------------------------------------------------------------- SAN DIEGO, 2012-05-04 16:05 CEST (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ('Apricus Bio' or the 'Company') (Nasdaq:APRI) (http://www.apricusbio.com) anno ...

04.05.2012 | Wirtschaft (allg.)

DGAP-News: Apricus Biosciences Receives Notice of Issuance for First Prevonco(TM) Patent in the United States

Apricus Biosciences, Inc. 26.04.2012 18:00 --------------------------------------------------------------------------- SAN DIEGO, 2012-04-26 18:00 CEST (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ('Apricus Bio' or the 'Company') (Nasdaq:APRI) (http://www.apricusbio.com), ann ...

26.04.2012 | Wirtschaft (allg.)

DGAP-News: Apricus Biosciences Announces Allowance of a NexACT(R) Technology-Based Patent in Europe for the Manufacture of DDAIP

Apricus Biosciences, Inc. 22.03.2012 12:00 --------------------------------------------------------------------------- SAN DIEGO, 2012-03-22 12:00 CET (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ('Apricus Bio' or the 'Company') (Nasdaq:APRI) (http://www.apricusbio.com), anno ...

22.03.2012 | Wirtschaft (allg.)

DGAP-News: Apricus Biosciences, San Diego Hospice and The Institute for Palliative Medicine Announce a Broad Clinical Research Program Using NexACT(R) Technology

Apricus Biosciences, Inc. 14.03.2012 15:05 --------------------------------------------------------------------------- SAN DIEGO, 2012-03-14 15:05 CET (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ('Apricus Bio' or the 'Company') (Nasdaq:APRI) (http://www.apricusbio.com), San ...

14.03.2012 | Wirtschaft (allg.)

DGAP-News: Apricus Biosciences CEO is Interviewed on CDTV.Net

Apricus Biosciences, Inc. 06.03.2012 16:01 --------------------------------------------------------------------------- Apricus Metamorphoses From a Clinical Stage Development Company to a Commercial Stage Specialty Pharmaceuticals Company SAN DIEGO, 2012-03-06 16:01 CET (GLOBE NEWSWIRE) -- Apri ...

06.03.2012 | Wirtschaft (allg.)

DGAP-News: Apricus Biosciences Announces Shareholder Update With New Focus as a Commercially-Driven Specialty Pharmaceutical Company

Apricus Biosciences, Inc. 16.02.2012 16:06 --------------------------------------------------------------------------- Company CEO Sets Goal to Grow Revenues in 2012 and Long-Term SAN DIEGO, 2012-02-16 16:06 CET (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ('Apricus Bio' or the ' ...

16.02.2012 | Wirtschaft (allg.)

DGAP-News: Apricus Bioscience's Wholly-Owned Subsidiary NexMed (USA) Signs Exclusive German Collaboration for Vitaros(R) for Erectile Dysfunction

Apricus Biosciences, Inc. 16.02.2012 01:19 --------------------------------------------------------------------------- SAN DIEGO, 2012-02-16 01:19 CET (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ('Apricus Bio' or the 'Company') (Nasdaq:APRI) (http://www.apricusbio.com) annou ...

16.02.2012 | Wirtschaft (allg.)

DGAP-News: Apricus Biosciences Announces Acquisition of NitroMist(TM) Rights Outside North America

Apricus Biosciences, Inc. 03.02.2012 15:41 --------------------------------------------------------------------------- SAN DIEGO, 2012-02-03 15:41 CET (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ('Apricus Bio' or the 'Company') (Nasdaq:APRI) (http://www.apricusbio.com) annou ...

03.02.2012 | Wirtschaft (allg.)

DGAP-News: Apricus Biosciences Expands Commercial Oncology Offerings Through Agreement With Pediatrx for U.S. Co-Promotion of GRANISOL(R) (Granisetron) Oral Solution and AQUORAL(TM) Spray and Purchase of Non-U.S. Rights to GRANISOL(R)

Apricus Biosciences, Inc. 27.01.2012 14:00 --------------------------------------------------------------------------- SAN DIEGO and CALIFON, N.J., 2012-01-27 14:00 CET (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ('Apricus Bio' or the 'Company') (Nasdaq:APRI) (http://www.apr ...

27.01.2012 | Wirtschaft (allg.)

DGAP-News: Apricus Biosciences Announces Allowance of Israeli Patent, Expanding Its Patent Portfolio for the Topical Treatment of Premature Ejaculation

Apricus Biosciences, Inc. 17.01.2012 16:03 --------------------------------------------------------------------------- SAN DIEGO, 2012-01-17 16:03 CET (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ('Apricus Bio' or the 'Company') (Nasdaq:APRI) (http://www.apricusbio.com) annou ...

17.01.2012 | Wirtschaft (allg.)

DGAP-News: Apricus Biosciences and Elis Pharma Sign License Agreement for MycoVa(TM) in the Middle East and the Gulf

Apricus Biosciences, Inc. 10.01.2012 15:51 --------------------------------------------------------------------------- Apricus Bio to Receive up to $2.1 Million, Plus Royalties SAN DIEGO and DUBAI, United Arab Emirates, 2012-01-10 15:51 CET (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ('Ap ...

10.01.2012 | Wirtschaft (allg.)

DGAP-News: Apricus Biosciences to Webcast Today's Presentation at Biotech Showcase(TM) 2012 in San Francisco

Apricus Biosciences, Inc. 09.01.2012 22:22 --------------------------------------------------------------------------- SAN DIEGO, 2012-01-09 22:22 CET (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ('Apricus Bio') (Nasdaq:APRI) (http://www.apricusbio.com) announced today that Chairman, P ...

09.01.2012 | Wirtschaft (allg.)

DGAP-News: Apricus Biosciences and Abbott Sign Exclusive Agreement to Market Vitaros(R) (Alprostadil) in Canada

Apricus Biosciences, Inc. 09.01.2012 18:29 --------------------------------------------------------------------------- SAN DIEGO, 2012-01-09 18:29 CET (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ('Apricus Bio') (Nasdaq:APRI) (http://www.apricusbio.com) announced today that it has ente ...

09.01.2012 | Wirtschaft (allg.)

DGAP-News: Apricus Biosciences CEO, Dr. Bassam Damaj, to Present at Biotech Showcase(TM) 2012 in San Francisco

Apricus Biosciences, Inc. 04.01.2012 15:49 --------------------------------------------------------------------------- SAN DIEGO, 2012-01-04 15:49 CET (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ('Apricus Bio') (Nasdaq:APRI) (http://www.apricusbio.com) announced today that Dr. Bassam ...

04.01.2012 | Wirtschaft (allg.)

DGAP-News: Apricus Biosciences and Stellar Pharmaceuticals Announce Exclusive License Agreement in Canada for the Commercialization of MycoVa(TM) for Onychomycosis

Apricus Biosciences, Inc. 03.01.2012 15:00 --------------------------------------------------------------------------- Apricus Bio Can Receive Up to Approximately $8 Million (Canadian) Plus Tiered Double Digit Royalties Under Multi-year Agreement ...

03.01.2012 | Wirtschaft (allg.)

DGAP-News: Apricus Biosciences Completes Acquisition of Topotarget USA, Inc.

Apricus Biosciences, Inc. 29.12.2011 18:30 --------------------------------------------------------------------------- To Rename the Newly Acquired Company, Apricus Pharmaceuticals USA, Inc. SAN DIEGO, Dec. 29, 2011 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ('Apricus Bio') (Nasdaq:A ...

29.12.2011 | Wirtschaft (allg.)

DGAP-News: Apricus Biosciences Launches Commercialization Arm With Definitive Agreement to Acquire Topotarget USA

Apricus Biosciences, Inc. 16.12.2011 14:00 --------------------------------------------------------------------------- First Acquisition by Apricus Bio of an FDA Approved and Marketed US Drug SAN DIEGO, 2011-12-16 14:00 CET (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ('Apricus Bio' o ...

16.12.2011 | Wirtschaft (allg.)

DGAP-News: Apricus Biosciences Press Release

Apricus Biosciences, Inc. 15.12.2011 16:18 --------------------------------------------------------------------------- Apricus Biosciences Announces Oral Presentation of Efficacy and Clinical Safety Data for Vitaros(R) and Femprox(R) at the African Society for Sexual Medicine Conference SAN DIE ...

15.12.2011 | Wirtschaft (allg.)

DGAP-News: Apricus Biosciences, Inc. Press Release

Apricus Biosciences, Inc. 12.12.2011 18:16 --------------------------------------------------------------------------- Apricus Biosciences' Vitaros(R) Podium Presentation Named Best Clinical Presentation 2011 (Male Sexual Disorder) by the Scientific Committee of the Congress for the European ...

12.12.2011 | Wirtschaft (allg.)

DGAP-News: Apricus Biosciences Announces Allowance of Additional NexACT(R) Patent in Japan

Apricus Biosciences, Inc. 08.12.2011 16:01 --------------------------------------------------------------------------- SAN DIEGO, 2011-12-08 16:01 CET (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ('Apricus Bio' or the 'Company') (Nasdaq:APRI) announced today that the Japanese ...

08.12.2011 | Wirtschaft (allg.)

DGAP-News: Apricus Biosciences Announces Appointment of Dr. Kleanthis G. Xanthopoulos to Its Board of Directors

Apricus Biosciences, Inc. 21.11.2011 15:51 --------------------------------------------------------------------------- SAN DIEGO, 2011-11-21 15:51 CET (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ('Apricus Bio' or the 'Company') (Nasdaq:APRI) announced today that Kleanthis G. ...

21.11.2011 | Wirtschaft (allg.)

DGAP-News: Apricus Biosciences Announces That Its NexACT(R) Partner Exodos Life Sciences Has Completed Its pre-IND Meeting With the FDA

Apricus Biosciences, Inc. 15.11.2011 15:30 --------------------------------------------------------------------------- Exodos Moves Closer to Filing a U.S. Investigational New Drug Application for Its Topically-Applied Formulation of Ketoprofen for Pain Relief SAN DIEGO, 2011-11-15 15:30 CET (G ...

15.11.2011 | Wirtschaft (allg.)

DGAP-News: Femprox(R) Phase III Clinical Data From Apricus Biosciences Chosen for a Presentation at the European Society for Sexual Medicine

Apricus Biosciences, Inc. 14.11.2011 15:47 --------------------------------------------------------------------------- SAN DIEGO, 2011-11-14 15:47 CET (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ('Apricus Bio' or the 'Company') (Nasdaq:APRI) announced today the acceptance of ...

14.11.2011 | Wirtschaft (allg.)

DGAP-News: Apricus Biosciences Announces Third Quarter 2011 Financial Results Conference Call

Apricus Biosciences, Inc. 11.11.2011 19:16 --------------------------------------------------------------------------- Conference Call/Webcast to be Held Tuesday, November 15, 2011 at 12:00 Noon ET SAN DIEGO, 2011-11-11 19:16 CET (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ('Apricus Bio&# ...

11.11.2011 | Wirtschaft (allg.)

DGAP-News: Apricus Biosciences Announces Issuance of Korean Patent, Expanding Its Patent Portfolio for Its Topical Cream to Treat Premature Ejaculation

Apricus Biosciences, Inc. 19.10.2011 15:30 --------------------------------------------------------------------------- SAN DIEGO, 2011-10-19 15:30 CEST (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ('Apricus Bio' or the 'Company') (Nasdaq:APRI) (http://www.apricusbio.com) ann ...

19.10.2011 | Wirtschaft (allg.)

DGAP-News: Apricus Biosciences Announces New Data Published in the International Journal of Pharmaceutics Confirming Efficiency of NexACT(R) Drug Delivery Technology

Apricus Biosciences, Inc. 13.10.2011 17:30 --------------------------------------------------------------------------- SAN DIEGO, 2011-10-13 17:30 CEST (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ('Apricus Bio' or the 'Company') (Nasdaq:APRI) (http://www.apricusbio.com) anno ...

13.10.2011 | Wirtschaft (allg.)

DGAP-News: Apricus Biosciences to Present Poster of Femprox(R) Phase III Clinical Data at Upcoming Industry Conference

Apricus Biosciences, Inc. 06.10.2011 15:52 --------------------------------------------------------------------------- SAN DIEGO, 2011-10-06 15:52 CEST (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ('Apricus Bio' or the 'Company') (Nasdaq:APRI) (http://www.apricusbio.com) anno ...

06.10.2011 | Wirtschaft (allg.)

DGAP-News: Apricus Biosciences Announces Korean Patent Approval for MycoVa(TM) for Nail Fungus

Apricus Biosciences, Inc. 03.10.2011 17:03 --------------------------------------------------------------------------- CEO Foresees Expanded Asian Patent Coverage for MycoVa(TM) Product SAN DIEGO, 2011-10-03 17:03 CEST (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ('Apricus Bio' or the ...

03.10.2011 | Wirtschaft (allg.)

DGAP-News: Apricus Biosciences to Provide Overview of Rx and Consumer Healthcare Divisions at the 11th Annual Biotech in Europe Investor Forum

Apricus Biosciences, Inc. 09.09.2011 20:51 --------------------------------------------------------------------------- SAN DIEGO, 2011-09-09 20:51 CEST (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ('Apricus Bio') (Nasdaq:APRI) (http://www.apricusbio.com) announced today that Dr. Bassam ...

09.09.2011 | Wirtschaft (allg.)

DGAP-News: Apricus Biosciences Receives FDA Clearance for Its Third OTC Drug Containing NexACT(R) Technology

Apricus Biosciences, Inc. 31.08.2011 15:47 --------------------------------------------------------------------------- SAN DIEGO, 2011-08-31 15:47 CEST (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ('Apricus Bio' or the 'Company') (Nasdaq:APRI) (http://www.apricusbio.com) anno ...

31.08.2011 | Wirtschaft (allg.)

DGAP-News: Photo Release -- Apricus Biosciences Announces FDA Clearance for Its First Anti-Fungal OTC Drug (Tolnaftate-D(TM)) Containing NexACT(R) Technology

Apricus Biosciences, Inc. 18.08.2011 15:00 --------------------------------------------------------------------------- DDAIP Now Listed on U.S. Monograph for OTC Products SAN DIEGO, 2011-08-18 15:00 CEST (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ('Apricus Bio' or the 'Company& ...

18.08.2011 | Wirtschaft (allg.)

DGAP-News: Apricus Biosciences Announces Second Quarter 2011 Financial Results Conference Call

Apricus Biosciences, Inc. 11.08.2011 22:30 --------------------------------------------------------------------------- Conference Call/Webcast to be held Monday, August 15, 2011 at 10:00 a.m. ET SAN DIEGO, 2011-08-11 22:30 CEST (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ('Apricus Bio ...

11.08.2011 | Wirtschaft (allg.)

DGAP-News: Apricus Biosciences to File for Market Authorization to Sell Vitaros(R) for Erectile Dysfunction in Latin America

Apricus Biosciences, Inc. 08.08.2011 16:03 --------------------------------------------------------------------------- Potential Market Size for Vitaros(R) for Erectile Dysfunction in Brazil, Alone, is Approximately $347 Million, Based on IMS Health Data (2010) SAN DIEGO, 2011-08-08 16:03 CEST ...

08.08.2011 | Wirtschaft (allg.)

DGAP-News: Apricus Biosciences Provides Corporate Mid-Year Update

Apricus Biosciences, Inc. 04.08.2011 19:37 --------------------------------------------------------------------------- SAN DIEGO, Aug. 4, 2011 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ('Apricus Bio' or the 'Company') (Nasdaq:APRI) (http://www.apricusbio.com) announced tod ...

04.08.2011 | Wirtschaft (allg.)

DGAP-News: Apricus Biosciences Files Marketing Application for Vitaros(R) as a Treatment for Erectile Dysfunction in Switzerland

Apricus Biosciences, Inc. 19.07.2011 15:57 --------------------------------------------------------------------------- SAN DIEGO, 2011-07-19 15:57 CEST (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ('Apricus Bio') (Nasdaq:APRI) announced today its filing of a marketing application for V ...

19.07.2011 | Wirtschaft (allg.)

DGAP-News: Apricus Biosciences' Marketing Application for Vitaros(R), for the Treatment of Erectile Dysfunction, is Accepted for Review in Europe

Apricus Biosciences, Inc. 28.06.2011 16:47 --------------------------------------------------------------------------- SAN DIEGO, 2011-06-28 16:47 CEST (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ('Apricus Bio') (Nasdaq:APRI) announced today that its marketing application for Vitaros( ...

28.06.2011 | Wirtschaft (allg.)

DGAP-News: Apricus Biosciences Reports Reanalysis of Its U.S. Phase III Trials for MycoVa(TM) Showing Drug is Effective in Mycological Cure Resulting in Eradication of Nail Fungus

Apricus Biosciences, Inc. 27.06.2011 16:17 --------------------------------------------------------------------------- Company to Revisit Its Regulatory Strategy for Potential U.S. and Canadian NDA and NDS Submissions for MycoVa(TM) SAN DIEGO, 2011-06-27 16:17 CEST (GLOBE NEWSWIRE) -- Apricus B ...

27.06.2011 | Wirtschaft (allg.)

DGAP-News: Apricus Bio CEO to Present Commercialization Plans for Vitaros(R) at Jefferies 2011 Global Healthcare Conference

Apricus Biosciences, Inc. 03.06.2011 16:17 --------------------------------------------------------------------------- Company Presentation Moved to June 8, 2011 at 2:00pm ET SAN DIEGO, 2011-06-03 16:17 CEST (GLOBE NEWSWIRE) -- Bassam Damaj, PhD., Chief Executive Officer of Apricus Biosciences, ...

03.06.2011 | Wirtschaft (allg.)

DGAP-News: Apricus Biosciences Appoints Steve Martin as Senior Vice President and Chief Financial Officer

Apricus Biosciences, Inc. 02.06.2011 18:00 --------------------------------------------------------------------------- SAN DIEGO, 2011-06-02 18:00 CEST (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ('Apricus Bio') (Nasdaq:APRI) today announced that Steve Martin has been appointed Senior ...

02.06.2011 | Wirtschaft (allg.)

DGAP-News: Apricus Biosciences Announces Issuance of Key Patent for RayVa(TM) for Raynaud's Phenomenon in Israel

Apricus Biosciences, Inc. 31.05.2011 15:55 --------------------------------------------------------------------------- Coverage Also Expands to Wound Healing, Inflammatory Skin Lesions and Certain Skin Conditions SAN DIEGO, 2011-05-31 15:55 CEST (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (&# ...

31.05.2011 | Wirtschaft (allg.)

DGAP-News: Apricus Biosciences' CEO to Present at Jefferies 2011 Global Healthcare Conference

Apricus Biosciences, Inc. 26.05.2011 19:32 --------------------------------------------------------------------------- SAN DIEGO, 2011-05-26 19:32 CEST (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ('Apricus Bio') (Nasdaq:APRI) (http://www.apricusbio.com) today announced that Bassam Dam ...

26.05.2011 | Wirtschaft (allg.)

DGAP-News: Apricus Biosciences to Present at the Euro-Biotech Partnering Forum 2011 to Further Its Partnership Efforts

Apricus Biosciences, Inc. 23.05.2011 19:38 --------------------------------------------------------------------------- SAN DIEGO, 2011-05-23 19:37 CEST (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ('Apricus Bio') (Nasdaq:APRI) (http://www.apricusbio.com) today announced that Linda Smib ...

23.05.2011 | Wirtschaft (allg.)

DGAP-News: Apricus Biosciences Will Request Approval of Vitaros(R) as a Treatment for Erectile Dysfunction in Switzerland, Based on Guidance From Swiss Regulatory Authorities

Apricus Biosciences, Inc. 19.05.2011 14:45 --------------------------------------------------------------------------- SAN DIEGO, 2011-05-19 14:45 CEST (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ('Apricus Bio') (Nasdaq:APRI) announced today that it will file a marketing application i ...

19.05.2011 | Wirtschaft (allg.)

DGAP-News: Apricus Biosciences CEO is Interviewed on CDTV.net

Apricus Biosciences, Inc. 18.05.2011 17:08 --------------------------------------------------------------------------- SAN DIEGO, 2011-05-18 17:07 CEST (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ('Apricus Bio') (Nasdaq:APRI) (http://www.apricusbio.com) announced today that Chief Exec ...

18.05.2011 | Wirtschaft (allg.)

DGAP-News: Apricus Biosciences Announces First Quarter 2011 Financial Results Conference Call

Apricus Biosciences, Inc. 10.05.2011 15:21 --------------------------------------------------------------------------- Conference Call/Webcast to be Held Friday, May 13, 2011 at 1:00 p.m. ETSAN DIEGO, May 10, 2011 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ('Apricus Bio') (Nasdaq:APR ...

10.05.2011 | Wirtschaft (allg.)

DGAP-News: Apricus Biosciences Requests Approval of Vitaros(R) as a Treatment for Erectile Dysfunction in Europe

Apricus Biosciences, Inc. 28.04.2011 16:06 --------------------------------------------------------------------------- Current Annual Market for Erectile Dysfunction in Europe is Estimated at Approximately $1.1 Billion SAN DIEGO, 2011-04-28 16:06 CEST (GLOBE NEWSWIRE) -- Apricus Biosciences, In ...

28.04.2011 | Wirtschaft (allg.)

DGAP-News: Apricus Biosciences to Present at the FSX Investor Conference in San Francisco on April 28, 2011

Apricus Biosciences, Inc. 27.04.2011 19:17 --------------------------------------------------------------------------- SAN DIEGO, April 27, 2011 (GLOBE NEWSWIRE) -- Apricus Biosciences ('Apricus Bio') (Nasdaq:APRI) today announced that Ed Cox, Vice President Corporate Development and In ...

27.04.2011 | Wirtschaft (allg.)

DGAP-News: Apricus Biosciences Files for Orphan Drug Designation for RayVa(TM)

Apricus Biosciences, Inc. 13.04.2011 19:11 --------------------------------------------------------------------------- Drug Intended for the Treatment of Raynaud's Phenomena, Secondary to Systemic Sclerosis SAN DIEGO, 2011-04-13 19:11 CEST (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (� ...

13.04.2011 | Wirtschaft (allg.)

DGAP-News: Apricus Biosciences' CEO Interviewed by WallStreetCorner.com

Apricus Biosciences, Inc. 05.04.2011 18:36 --------------------------------------------------------------------------- SAN DIEGO, 2011-04-05 18:36 CEST (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ('Apricus Bio') (Nasdaq:APRI) (http://www.apricusbio.com) announced today that Chairman, ...

05.04.2011 | Wirtschaft (allg.)

DGAP-News: Apricus Biosciences Expands Patent Coverage in Mexico for Its Erectile Dysfunction Drug, Vitaros(R)

Apricus Biosciences, Inc. 31.03.2011 16:41 --------------------------------------------------------------------------- Current Annual Market for Erectile Dysfunction in Mexico is Estimated at Between $175 to $200 Million SAN DIEGO, 2011-03-31 16:41 CEST (GLOBE NEWSWIRE) --Apricus Biosciences, I ...

31.03.2011 | Wirtschaft (allg.)

DGAP-News: Apricus Biosciences Adopts Shareholder Rights Plan

Apricus Biosciences, Inc. 24.03.2011 14:53 --------------------------------------------------------------------------- SAN DIEGO, 2011-03-24 14:53 CET (GLOBE NEWSWIRE) --Apricus Biosciences, Inc. ('Apricus Bio') (Nasdaq:APRI) announced today that its Board of Directors (the 'Boar ...

24.03.2011 | Wirtschaft (allg.)

DGAP-News: Apricus Biosciences Announces Formation of Clinical Advisory Board as Part of Its Plans to Further the Clinical Development of Femprox(R)

Apricus Biosciences, Inc. 15.03.2011 15:08 --------------------------------------------------------------------------- SAN DIEGO, 2011-03-15 15:08 CET (GLOBE NEWSWIRE) --Apricus Biosciences, Inc., ('Apricus Bio') (Nasdaq:APRI) today announced the formation of a Male and Female Sexual ...

15.03.2011 | Wirtschaft (allg.)

DGAP-News: Apricus Biosciences to Present at the Bio-Europe Spring 2011 Conference

Apricus Biosciences, Inc. 10.03.2011 15:57 --------------------------------------------------------------------------- SAN DIEGO, 2011-03-10 15:57 CET (GLOBE NEWSWIRE) --Apricus Biosciences, Inc. ('Apricus Bio') (Nasdaq:APRI) (http://www.apricusbio.com) today announced that Linda Smib ...

10.03.2011 | Wirtschaft (allg.)

DGAP-News: Apricus Biosciences Announces Removal of Auditor's 'Going Concern' Opinion From Its 2010 Form 10-K and Increased Cash Reserves

Apricus Biosciences, Inc. 08.03.2011 15:57 --------------------------------------------------------------------------- SAN DIEGO, 2011-03-08 15:57 CET (GLOBE NEWSWIRE) --Apricus Biosciences, Inc. ('Apricus Bio') (Nasdaq:APRI) announced today that the going concern paragraph has been r ...

08.03.2011 | Wirtschaft (allg.)

DGAP-News: Apricus Biosciences Announces Expanded European Patent Coverage for MycoVa(TM) for Nail Fungus

Apricus Biosciences, Inc. 01.03.2011 15:14 --------------------------------------------------------------------------- SAN DIEGO, 2011-03-01 15:14 CET (GLOBE NEWSWIRE) --Apricus Biosciences, Inc. ('Apricus Bio') (Nasdaq:APRI) announced today that the European Patent Office ('EPO& ...

01.03.2011 | Wirtschaft (allg.)

DGAP-News: Apricus Biosciences and FDA Initiate PrevOnco(TM) SPA Phase III Clinical Protocol Discussion

Apricus Biosciences, Inc. 17.02.2011 15:11 --------------------------------------------------------------------------- SAN DIEGO, 2011-02-17 15:11 CET (GLOBE NEWSWIRE) --Apricus Biosciences, Inc. ('Apricus Bio') (Nasdaq:APRI), announced today that it is currently in discussions with t ...

17.02.2011 | Wirtschaft (allg.)

DGAP-News: Apricus Biosciences and Neopharm Group Sign Licensing Agreement for Vitaros(R) in Israel for up to $4.35 Million, Plus Royalties

Apricus Biosciences, Inc. 14.02.2011 16:14 --------------------------------------------------------------------------- SAN DIEGO, 2011-02-14 16:14 CET (GLOBE NEWSWIRE) --Apricus Biosciences, Inc. ('Apricus Bio') (Nasdaq:APRI), announced today that it has entered into a licensing agree ...

14.02.2011 | Wirtschaft (allg.)

DGAP-News: Apricus Biosciences, Inc. Press Release

Apricus Biosciences, Inc. 19.01.2011 17:41 --------------------------------------------------------------------------- Apricus Biosciences Reports Additional Analysis Showing That MycoVa(TM) is as Effective for the Treatment of Nail Fungus as the Current European Standard of Care for Topical Ther ...

19.01.2011 | Wirtschaft (allg.)

Apricus Biosciences, Inc.

Neu hier ?

Werbung

Community

Sponsoren

Firmenverzeichniss